Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 809 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
12 Мб
Скачать
56
A. A. Samara
and studies with data from multiple RCTS; stud­ies with data from a single RCT are evaluated with the second highest level of evidence (Level B) [16] (Fig.5.1).
The quality of surgical research has increased in recent decades, but traditionally the scientic surgical community does not favour the conduct
Table 5.1 Health-related quality of life denitions
Authors Denition Hays RD
etal. [8]
Torrance GW [9]
Ebrahim S [10]
Gold MR etal. [11]
Abbreviations: HR-QoL Health-related Quality of Life, QALYs Quality-adjusted life years
HR-QoL is how well a person functions in life and his or her perceived wellbeing in physical, mental, and social domains of health
HR-QoL is an all-inclusive concept incorporating all factors that impact upon an individual’s life. Health-related quality of life includes only those factors that are part of an individual’s health
HR-QoL are those aspects of self­perceived well-being that are related to or affected by the presence of disease or treatment
HR-QoL can refer to the values assigned to different health states. These values used to calculate the QALY are on a scale where zero is equal to dead and one is equal to full health
of RCTs [17, 18] since many of the “gold stan­dard” operating techniques were established prior to the introduction of RCTs in 1950s. Furthermore, and as the benet for the patients remains clear it may be considered unethical to treat a patient group with a novel or placebo treatment [17]. Other factors associated with a lower preference for RCTs include issues with blinding techniques, effects of surgeon factor, variable learning curves of each intervention and special circumstances as emergency surgeries [17, 19]. Despite these obstacles, growing inter­est in RCTs is apparent over the last two decades as surgeons receive further education and train­ing related to appropriate health research methodologies.
In the present chapter, we aim to present the main results of Randomised Controlled Trials evaluating Quality of Life as an outcome in sur­gical patients. Due to the heterogeneity of this subject, including RCTs in patients of all surgi­cal aspects (cardiac, gastrointestinal and gyneco­logical surgery) and the per se variations of different systems regarding operative techniques and morbidity, a system-based approach was followed.
Fig. 5.1 Level of evidence pyramid. Adapted from SpingerLink
5 Quality ofLife asEndpoint inSurgical Randomised Controlled Trials
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
57
Cardiac Surgery
Cardiovascular diseases remain one of the lead­ing causes of morbidity and mortality world­wide with a high impact on patients’ HR-QoL [20]. Over the last decades cardiac surgery has made vast progress in reducing mortality and major postoperative complications. In this con­text, a key indicator of surgical outcome with growing popularity is the impact on functional status of patients, as well as the ability and time patients can resume or improve their day-to-day lives [21].
Improvements in surgical techniques and enhanced understanding of the pathophysiology of mitral valve (MV) dysfunction have led to improved outcomes. Current guidelines recom­mend early intervention for asymptomatic patients with severe degenerative mitral regurgi­tation (MR) [22]. In this context, a recent system­atic review with HR-QoL as an outcome reports acceptable postinterventional HR-QoL compara­ble to the matched general population, and identi­ed patient-specic and surgical-specic factors associated with poorer long-term HR-QoL [22]. Table5.2 displays ve recent RCTs [2327, 40] comparing different techniques and approaches with HR-QoL as an outcome. Minimally invasive procedures (chordal-sparing replacement) or approaches (minithoracotomy) and transcatheter technologies have demonstrated satisfactory results regarding HR-QoL, compared with the conventional standard techniques. The follow-up period generally ranged between 12 and 36 months. It is also noteworthy that variant tools and scores were used to determine HR-QoL, with Short-Form 36 (SF-36) the most commonly used.
Many RCTs have been conducted to compare coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) regarding mortality and myocardial infarction rates; however, there is limited up-to-date evi­dence from RCTs about changes in QoL follow­ing treatment for acute coronary syndrome (ACS) patients. A recently published meta-anal­ysis concluded that the mean QoL of patients diagnosed with ACS was higher after receiving treatment compared to baseline, with patients in the CABG group having slightly higher QoL gains compared to those in the PCI group [41]. More specically, results from RCTs comparing HR-QoL of patients after revascularization of coronary arteries with CABG and PCI suggest that both methods are associated with a postint­erventional increase in HR-QoL, however CABG offers a slightly better outcome com­pared with the percutaneous technique (Table 5.2) [2835]. Moreover, RCTs [3639] were used to evaluate the standard CABG tech­nique with off-pump coronary artery bypass (OPCAB) in terms of HR-QoL. The OPCAB technique offers no signicant advantages over traditional CABG in terms of HR-QoL [42]; however, a cost-effectiveness RCT suggested that OPCAB surgery offers similar results with CABG over a 6-month period at signicantly less cost [38]. The follow-up period ranged between 6 and 72 months, with a 12-month period being the most common. Similarly with RCTs regarding mitral valve repair, different tools and scores were used to determine HR-QoL, with SF-36 and Seattle Angina Questionnaire (SAQ) being the most commonly used.
58
TMVr provided substantial benets in
terms of symptoms, functional status, and
quality of life
Better quality-adjusted survival at 10 years
when mitral-valve replacement is
compared to repair for severe ischemic MR
A statistically signicant amelioration was
evidenced within all the SF-36 domains
irrespective of the approach
There was no signicant difference
between the two study groups with respect
to any measure of quality of life or
functional status at 12 months. SF-12 score
improved over baseline in physical health
of 16.6% in the repair group and 18.4% in
the replacement group
There was a statistically signicant
difference only regarding amelioration in
physical status in 30-days. The results were
equal regarding mental status in 30-days
and both mental and physical status in
12-months
Both CABG and DES-PCI were associated
with substantial and sustained quality-of-
life benets over 5 years of follow-up.
CABG resulted in greater angina relief,
A. A. Samara
although the absolute treatment benet was
small.
CABG provides slightly better
intermediate term health status and quality
of life than DES-PCI—mainly between 6
months and 2 years after initial treatment
Number
of
patients QoL instrument Follow up Conclusion regarding QoL
months
614 KCCQ and SF-36 score 24
transcatheter mitral
valve repair (TMVr)
24
months
longitudinal SF-6D
251 QALYs calculated from
vs. standard medical
care
mitral-valve repair or
replacement
3 years
on
average
months
scores
class
80 SF-36 and functional
minithoracotomy vs.
251 SF-12 score 12
median sternotomy
mitral-valve repair vs.
chordal-sparing
replacement
months
279 SF-36 score 12
percutaneous repair vs.
conventional surgery
60
months
SF-36 score
1800 SAQ Questionnaire and
PCI using drug-eluting
stents vs. CABG
surgery
months
1880 SAQ Questionnaire 24
PCI using drug-eluting
stents vs. CABG
surgery
Table 5.2 RCTs in cardiac surgery
symptomatic patients with
HF
2019 Mitral-valve repair in
Author Year Operation Comparison
Arnold etal.
[23]
ischemic mitral
2018 Mitral-valve repair for
Ferket etal.
[24]
regurgitation
2014 Mitral-valve repair for
Nasso etal.
Barlow disease
2014 Mitral-valve repair for
[25]
Acker etal.
ischemic mitral
regurgitation
[26]
replacement
2011 Mitral-valve repair or
Feldman
etal. [27]
patients with 3-vessel or left
main coronary artery
disease
2017 Coronary arteries surgery in
Abdallah
etal. [28]
patients with diabetes
mellitus and multivessel
coronary artery disease
2013 Coronary arteries surgery in
Abdallah
etal. [29]
5 Quality ofLife asEndpoint inSurgical Randomised Controlled Trials
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
There is a signicant difference in
health-related quality of life 12-months.
The GABG group had better physical
function compared with the percutaneous
group
The mental health status remained similar
There was greater relief from angina after
CABG than after PCI at 6 and 12 months,
although the extent of the benet was small
The quality of life was better in both
CABG and PCI groups compared to MT
after 1 year of follow-up. Patients in the
CABG group presented the greater and
progressive improvement of QoL
in both groups
High-risk patients with medically
refractory ischemia randomised to PCI
versus CABG surgery have equivalent
6-month HRQL
Over 12 months of follow-up, health status
was improved to a greater extent for
CABG patients than for PCI patients,
primarily due to the adverse inuence of
restenosis after PCI
There is no g difference in health-related
quality of life 1 year after CABG or PCI,
however, more favourable outcomes found
in degree of perceived energy in the CABG
group
59
(continued)
Number
of
patients QoL instrument Follow up Conclusion regarding QoL
12
months
months
SF-36 score, EQ-5D
1800 SAQ questionnaire,
PCI using drug-eluting
stents vs. CABG
surgery
542 SF-36 score 12
Medical therapy (MT)
vs. PCI vs. CABG
surgery
PCI vs. CABG surgery 543 SF-36 score 12
months
PCI vs. CABG surgery 389 SF-36 score 6
months
PCI vs. CABG surgery 475 SAQ Questionnaire 12
months
12
months
Prole and a set of 12
other questions
PCI vs. CABG surgery 154 Nottingham Health
coronary syndromes
without ST-segment
patients with 3-vessel or left
main coronary artery
disease
patients with stable
coronary artery disease
2011 Coronary arteries surgery in
Author Year Operation Comparison
Cohen etal.
[30]
2007 Coronary arteries surgery in
Favarato
etal. [31]
elevation
2005 Revascularization in acute
Szygula-
Jurkiewicz
etal. [32]
for high-risk patients with
medically refractory
ischemia
arteries surgery
2003 Coronary arteries surgery
Rumsfeld
etal. [33]
2002 Revascularization coronary
Borkon etal.
[34]
arteries surgery
1999 Revascularization coronary
Wahrborg
etal. [35]
60
Long-term health outcomes with off-pump
coronary artery bypass are similar to those
with coronary artery bypass grafting with
cardiopulmonary bypass when both
operations are performed by experienced
surgeons
There was no statistically signicant
difference between the two groups
OPCAB surgery offered similar health
benets to CABG over a 6-month period,
but at signicantly less cost
In low-risk patients undergoing CABG
surgery, avoiding the use of
72–96
months
months
months
60
months
cardiopulmonary bypass had no effect on
5-year cognitive or cardiac outcomes
A. A. Samara
Number
of
patients QoL instrument Follow up Conclusion regarding QoL
EuroQoL
299 SF-36, CROQ, SAQ,
OPCAB vs. CABG
surgery
arteries surgery
2009 Revascularization coronary
202 CCS, SF-36 12
OPCAB vs. CABG
surgery
arteries surgery
2008 Revascularization coronary
tests, SF-36, EuroQoL
168 WHOQOL 6
OPCAB vs. CABG
2006 Revascularization coronary
281 10 neuropsychological
surgery
OPCAB vs. CABG
surgery
arteries surgery
arteries surgery in low risk
patients
2007 Revascularization coronary
Table 5.2 (continued)
Author Year Operation Comparison
Angelini
etal. [36]
Nogueira
etal. [37]
Al Ruzzeh
etal. [38]
van Dijk
etal. [39]
Abbreviations: HF Heart failure, KCCQ Kansas City Cardiomyopathy Questionnaire, SF-36 Short-Form 36, QALYs quality-adjusted life years, PCI percutaneous coronary
Revascularization Outcome Questionnaire, OPCAB off-pump coronary artery bypass, CCS Canadian Cardiovascular Score, WHOQOL World Health Organization
intervention, CABG coronary artery bypass graft, SAQ Seattle Angina Questionnaire, EQ-5D European Quality of Life–5 Dimensions instrument, CROQ Coronary
Quality-of-Life
5 Quality ofLife asEndpoint inSurgical Randomised Controlled Trials
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
61
Gastrointestinal Surgery
Many RCTs have been conducted in recent decades to compare operative results in terms of overall survival, disease-free survival, recurrence rates in gastrointestinal cancer surgery, and mor­tality and morbidity in operations for benign con­ditions (such as diverticulosis). However, data on the impact of these operations related to patients’ postoperative QoL are still scarce. The impact of functional decits following colorectal opera­tions on QoL has been repeatedly conrmed; based on these results different methods and techniques have been tested [42]. Bariatric and metabolic surgery was developed to improve the impaired QoL in morbidly obese patients, which is the primary reason why patients seek medical advice [43].
Following the introduction of laparoscopic surgery in the early 1990s, the feasibility and safety of a laparoscopic approach in colorectal surgery were determined by the results of several RCTs [44]. In addition, a few RCTs [4552] were conducted to determine if the operative approach had an impact on patients’ HR-QoL (Table5.3). In 2010 Bartels etal. [59] systemati­cally reviewed all available data from RCTs that compared open and laparoscopic colectomy in terms of QoL, and concluded that there was no clinically relevant difference. There was however great heterogeneity between the data, including
both patients with colorectal cancer and benign diseases (diverticulosis and inammatory bowel disease). Furthermore, a variety of tools and scores were used to determine QoL, making it difcult to conduct a pool data analysis. SF-36 and EORT-C30 were the most commonly used tools comparing QoL after open and laparoscopic colectomy.
It is estimated that nearly 35% of patients who undergo total mesorectal excision (TME) for rec­tal cancer will ultimately develop the renowned low anterior resection syndrome (LARS) charac­terized by severe anorectal dysfunction [60]. This postoperative condition has a signicant impact on patients’ QoL.Different rectal reconstructive techniques have been introduced and tested on their results regarding postoperative bowel func­tion and HR-QoL, with J-pouch being the most widely applied [61]. A recently published pooled analysis of RCTs comparing J-pouch and a side­to- end anastomosis suggests that both techniques are comparable in terms of bowel functional out­comes, QoL, and surgical outcomes [62]. Table 5.2 presents some of the most important RCTs [5358] comparing J-pouch with a straight or side-to-end anastomosis. As study results were controversial in many cases, J-pouch is associ­ated with an improved quality of life compared with straight anastomosis, but the results are sim­ilar when comparing J-pouch and side-to-end anastomosis [63].
62
QοL benets were found
in laparoscopic group
compared with standard
open colectomy
resection was associated
with a better quality of
8 weeks Only minimal short-term
life in the rst 12 months
after surgery compared
with open surgery
for colon cancer
improved quality of life
during the rst
postoperative month
patterns and no
differences in any of the
functioning scales or
symptoms between the
two groups
differences were seen
between patients
undergoing laparoscopic
or open surgery in
HRQL scores for the
QLQ C30 or CR38 at
A. A. Samara
each assessment point
was associated with an
improved quality of life
QoL
Number of
patients QoL instrument Follow up Conclusion regarding QoL
449 QLI, SDS, Global
open
391 SF-36 48 months Laparoscopic colorectal
Laparoscopic vs.
open
cancer
285 EORTC-C30, EQ-5D 12 weeks Laparoscopic resection
open
EORTC-C30 and C38 36 months There were similar
794 (696 for
QoL)
Laparoscopic vs.
open
cancer
62 EORTC-C30 and C38 12 months No signicance
Laparoscopic vs.
open
cancer
104 SF-36 6 weeks Laparoscopic approach
Laparoscopic vs.
open
symptomatic
diverticulitis
2009 Sigmoid resection for
Table 5.3 RCTs in gastrointestinal surgery
Author Year Operation Comparison
Weeks etal. [44] 2002 Colectomy for cancer Laparoscopic vs.
Braga etal. [45] 2005 Colorectal resection for
Janson etal. [46] 2007 Colectomy for cancer Laparoscopic vs.
Jayne etal. [47] 2007 Colorectal resection for
King etal. [48] 2008 Colorectal resection for
Klarenbeek etal.
[49]
5 Quality ofLife asEndpoint inSurgical Randomised Controlled Trials
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
QoL was similar between
the two groups
the two groups
gain in quality of life
maintained at 2 months
postoperatively for those
who received
laparoscopic relative to
open colonic resection
difference regarding
HR-QoL
difference regarding
HR-QoL
a better HRQL
n improved QoL in the
early months after
surgery compared with
patients who receive a
straight coloanal
63
(continued)
anastomosis
Number of
patients QoL instrument Follow up Conclusion regarding QoL
55 SF-36, GIQLI 6.7 years
Laparoscopic vs.
median
60 SF-36 and GIQLI 12 weeks QoL was similar between
open
Laparoscopic vs.
open
2 months There was a short-term
Symptoms Distress
Scale
592 Global QoL, QLI,
open
74 EORTC-C30 6 months There was no signicant
J-pouch vs. straight
88 FIQL 12 months There was no signicant
coloanal
anastomosis
J-pouch vs.
coloplasty pouch
12 months Patients with J pouch had
QLQ-CR38 and
GIQLI
64 EORTC QLQ-C30,
J-pouch vs. straight
50 FISI, FIQL 12 months Patients with J pouch had
coloanal
anastomosis
J-pouch vs. straight
coloanal
anastomosis
Chron disease
ileal pouch anal
anastomosis for
ulcerative colitis and
familial adenomatous
polyposis
2004 Proctocolectomy with
Author Year Operation Comparison
Eshuis etal. [50] 2010 Ileocolic resection for
Maartense etal.
[51]
2018 Colectomy for cancer Laparoscopic vs.
McCombie etal.
[52]
for rectal cancer
Fürst etal. [53] 2002 Low anterior resection
resection for rectal cancer
Ho etal. [54] 2002 Ultralow anterior
for rectal cancer
Sailer etal. [55] 2002 Low anterior resection
resection for rectal cancer
Park etal. [56] 2005 Ultralow anterior
64
similar functional
outcomes and QoL
during the rst year after
stoma closure
had comparable results
A. A. Samara
on QoL
12 months Both techniques produce
Overactive Bladder-
Female Sexual
Function Index and
74 SF-36, FISI, SHIM,
Number of
patients QoL instrument Follow up Conclusion regarding QoL
J-pouch vs. a
side-to-end
anastomosis
12 months Both techniques produce
Validated Form
and SF-36
107 EORTC-QLQ-CR38
J-pouch vs. a
side-to-end
anastomosis
(continued)
Author Year Operation Comparison
Table 5.3
Laparoscopic hand-
assisted low anterior
resection for rectal cancer
2017
Okkabaz etal.
[57]
2012 Low anterior resection
Doeksen etal.
for rectal cancer after
neo-adjuvant
radiotherapy
[58]
SF-36 Short-Form 36, EORTC European Organization for Research and Treatment of Cancer, SDS Symptom Distress Scale, GIQLI GastroIntestinal Quality of Life Index, QLI
QoL Index, FIQL Fecal Incontinence Quality of Life Scale, GIQLI Gastro-intestinal Quality of Life Index, FISI fecal incontinence severity index, SHIM Sexual Health Inventory
for Men
5 Quality ofLife asEndpoint inSurgical Randomised Controlled Trials
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
65
Gynecological Surgery
Surgery plays a pivotal role in the survival of patients with gynecological cancers, as well as a key role in the management of symptoms for benign conditions. Gynecological surgical patients can be particularly vulnerable to distress, facing additional preoperative anxiety consider­ing issues such as female self-image, altered sex­ual function, and loss of fertility [64]. Moreover, patients with gynecological pathology face sig­nicant deterioration in HR-QoL regardless of the existence of a malignant disease. In some cases, patients with a benign condition suffer from a greater scale of pain and experience greater QoL deterioration compared to patients with malignant disease [65].
Endometriosis is a benign condition causing chronic pain and dysmenorrhea in young women, with a major impact on their daily lives. HR-QoL in women with endometriosis is a growing con­cern increasingly voiced by both health profes­sionals and patients themselves [66]. Several RCTs have been conducted with QoL as an end­point comparing different medical treatments, however only a few RCTs comparing surgical management of endometriosis have been pub­lished to date [6771]. These trials compare dif­ferent operative techniques (robotic vs. laparoscopic), surgery or placebo treatment and a conservative or radical surgery (Table5.4). The results of the above studies indicate that surgical management of endometriosis has a positive
impact on patients’ QoL, regardless of the opera­tive technique or approach followed. Nevertheless, considering the small number of patients included in the RCTs and the heterogeneity in scales used to evaluate QoL in endometriosis, these results must be interpreted with caution.
Treatment of gynecological cancers affect all dimensions of a patient’s life and affect the HR-QoL of females. To the best of our knowl­edge, only two large RCTs have been conducted in patients who underwent surgery for gyneco­logical cancer, comparing open and minimally invasive hysterectomy in terms of HR-QoL for cervical and endometrial cancer, respectively [72, 73]. Publication of the LACC (Laparoscopic Approach to Cervical Cancer) trial in 2018 led to drastic changes in recommendations for opera­tive treatment of cervical cancer patients, proving that recurrence rates are higher and disease-free survival is lower for minimally invasive radical hysterectomy than for open surgery, while post­operative QoL is similar between the treatment groups [72]. Furthermore, endometrial cancer patients who had a hysterectomy performed with a minimal invasive technique had enhanced QoL improvement from baseline during the early and later phases of recovery and a favorable adverse event prole that open surgery [73]. Considering the scarcity of data on QoL in gynecological can­cer patients undergoing surgery and the importance of QoL in these patients, further RCTs comparing HR-QoL must be conducted in this study population to provide solid evidence.